| 000 | 01719 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517171653.0 | ||
| 264 | 0 | _c20180604 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1873-7544 | ||
| 024 | 7 |
_a10.1016/j.neuroscience.2017.08.030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamamoto, Naoki | |
| 245 | 0 | 0 |
_aEpigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways. _h[electronic resource] |
| 260 |
_bNeuroscience _cOct 2017 |
||
| 300 |
_a70-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAstrocytes _xdrug effects |
| 650 | 0 | 4 |
_aCatechin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
| 650 | 0 | 4 |
_aExtracellular Space _xdrug effects |
| 650 | 0 | 4 |
_aIsoflavones _xpharmacology |
| 650 | 0 | 4 |
_aNeprilysin _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProteolysis _xdrug effects |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aShibata, Mari | |
| 700 | 1 | _aIshikuro, Ryo | |
| 700 | 1 | _aTanida, Mamoru | |
| 700 | 1 | _aTaniguchi, Yuina | |
| 700 | 1 | _aIkeda-Matsuo, Yuri | |
| 700 | 1 | _aSobue, Kazuya | |
| 773 | 0 |
_tNeuroscience _gvol. 362 _gp. 70-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2017.08.030 _zAvailable from publisher's website |
| 999 |
_c27500806 _d27500806 |
||